#331.2 IT: OM1 Innovation Theater: Revolutionizing Prospective Studies and Registries with Automation and AI

#331.2 IT: OM1 Innovation Theater: Revolutionizing Prospective Studies and Registries with Automation and AI

Wednesday, June 19, 2024 11:15 AM to 11:45 AM · 30 min. (US/Pacific)
Exhibit Hall Theater #2
19: InnovationTheaters

Information

Join us for an insightful exploration of how automated real-world data collection, powered by advanced AI technologies, transforms clinical research. This session will demonstrate how these innovations not only accelerate study timelines and reduce costs but also redefine the approach to prospective studies and registries. Discover how this technological synergy is driving a paradigm shift, ushering in a new era of efficiency and effectiveness in life sciences.
OM12309OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-Gen A.I. platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. Our unprecedented innovation takes RWE from Bench-to-Practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research. We do things differently. We are pushing the boundaries of healthcare, reimagining how industry, providers, payers, and patients use real-world evidence. We are globally recognized for the integration of cutting-edge AI and data technologies. As pioneers in the field, our commitment to leveraging technology propels healthcare transformation, enhancing patient outcomes and setting new industry benchmarks.

Registered attendees

Barbara Isquith Arone
Barbara Isquith Arone
Vice President, Evidence Generation for Medical AffairsIQVIA
Christina Mack
Christina Mack
Chief Scientific Officer, Real-World SolutionsIQVIA
Claudia Salinas
Claudia Salinas
Senior Director, GPS PharmacoepidemiologyEli Lilly and Company

Log in